Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
6.14
-0.47 (-7.11%)
At close: Jul 13, 2026, 4:00 PM EDT
6.00
-0.14 (-2.28%)
After-hours: Jul 13, 2026, 7:00 PM EDT

Basel Medical Group Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22
1033---
Market Cap Growth
-71.57%----
Enterprise Value
10.9435.04000
Last Close Price
6.1421.36---
PS Ratio
0.863.75---
PB Ratio
2.127.82---
P/TBV Ratio
18.376.15---
EV/Sales Ratio
0.953.93---
Debt / Equity Ratio
0.930.540.210.621.61
Debt / EBITDA Ratio
--1.622.873.72
Debt / FCF Ratio
--1.722.783.76
Net Debt / Equity Ratio
1.220.370.311.092.32
Net Debt / EBITDA Ratio
-4.47-0.180.882.383.15
Net Debt / FCF Ratio
-2.99-0.440.942.313.18
Asset Turnover
0.830.650.630.600.63
Inventory Turnover
58.6531.9070.6667.9288.93
Quick Ratio
1.841.232.032.272.17
Current Ratio
1.881.312.262.282.18
Return on Equity (ROE)
-147.37%-163.64%31.77%38.79%64.40%
Return on Assets (ROA)
-26.22%-69.32%11.53%12.15%12.78%
Return on Invested Capital (ROIC)
-32.45%-139.61%17.09%16.47%17.52%
Return on Capital Employed (ROCE)
-46.28%-142.69%23.48%21.09%22.30%
Buyback Yield / Dilution
-23.41%-15.60%0.00%0.00%-
Total Shareholder Return
-23.41%-15.60%0.00%0.00%-
SEC Filings: 10-K · 10-Q